Satya Dash

2.7k citations

58 papers · 1.8k indexed · 1 hit paper · h-index 19

Impact in

Endocrinology, Diabetes and Metabolism top 2%
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
- Diabetes, Cardiovascular Risks, and Lipoproteins
Endocrine and Autonomic Systems top 5%

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 30
- Diabetes Treatment and Management 14
- Diet, Metabolism, and Disease 9
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
Endocrine and Autonomic Systems 9
- Regulation of Appetite and Obesity 9

Co-authors: Changting Xiao (23 shared papers)Gary F. Lewis (23 shared papers)Cecilia Morgantini (16 shared papers)Sanjeev Sockalingam (9 shared papers)Shohinee Sarma (1 shared paper)Linda Szeto (2 shared papers)Robert A. Hegele (1 shared paper)Robert Bandsma (1 shared paper)
Journals: Diabetes Obesity and Metabolism (10 papers)Diabetes (8 papers)Arteriosclerosis Thrombosis and Vascular Biology (6 papers)Canadian Journal of Cardiology (2 papers)Frontiers in Endocrinology (2 papers)
Partner nations: Canada United States United Kingdom

In The Last Decade

Satya Dash

56 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications 2021 · 265 citations

Peers

Countries citing papers authored by Satya Dash

Since Specialization

Citations

This map shows the geographic impact of Satya Dash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satya Dash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satya Dash more than expected).

Fields of papers citing papers by Satya Dash

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satya Dash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satya Dash. The network helps show where Satya Dash may publish in the future.

Co-authors

The 25 scholars most cited alongside Satya Dash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Satya Dash Line = papers co-authored together Satya Dash links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications Diabetes Obesity and Metabolism ·Shohinee Sarma, Sanjeev Sockalingam, Satya Dash Hit paper breakdown →	2021	265
2	Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol Diabetes ·Changting Xiao, Satya Dash, Cecilia Morgantini, Robert A. Hegele, Gary F. Lewis	2016	152
3	Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent International Journal of Obesity ·Stefano Romeo, Federica Sentinelli, Satya Dash, Giles S.H. Yeo, David B. Savage, Frida Leonetti, Danila Capoccia, Michela Incani, Cristina Maglio, Michelina Iacovino, Stephen O’Rahilly, Marco Giorgio Baroni	2009	149
4	New Insights into the Regulation of Chylomicron Production Annual Review of Nutrition ·Satya Dash, Changting Xiao, Cecilia Morgantini, Gary F. Lewis	2015	135
5	Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans Arteriosclerosis Thrombosis and Vascular Biology ·Changting Xiao, Robert Bandsma, Satya Dash, Linda Szeto, Gary F. Lewis	2012	129
6	High-Dose Resveratrol Treatment for 2 Weeks Inhibits Intestinal and Hepatic Lipoprotein Production in Overweight/Obese Men Arteriosclerosis Thrombosis and Vascular Biology ·Satya Dash, Changting Xiao, Cecilia Morgantini, Linda Szeto, Gary F. Lewis	2013	89
7	Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations Diabetes ·Satya Dash, Changting Xiao, Cecilia Morgantini, Khajag Koulajian, Gary F. Lewis	2014	85
8	A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia Proceedings of the National Academy of Sciences ·Satya Dash, Hiroyuki Sano, Justin J. Rochford, Robert K. Semple, Giles S.H. Yeo, Caroline S. S. Hyden, Maria A. Soos, James E. Clark, Andrew Rodin, Claudia Langenberg, C. Druet, Katherine A. Fawcett, Y.C. Loraine Tung, Nicholas J. Wareham, Inês Barroso, Gustav E. Lienhard, Stephen O’Rahilly, David B. Savage	2009	78
9	Glucagon-Like Peptide-2 Regulates Release of Chylomicrons From the Intestine Gastroenterology ·Satya Dash, Changting Xiao, Cecilia Morgantini, Philip W. Connelly, Bruce W. Patterson, Gary F. Lewis	2014	75
10	Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans Diabetes ·Changting Xiao, Satya Dash, Cecilia Morgantini, Bruce W. Patterson, Gary F. Lewis	2014	56
11	New and emerging regulators of intestinal lipoprotein secretion Atherosclerosis ·Changting Xiao, Satya Dash, Cecilia Morgantini, Gary F. Lewis	2014	48
12	Novel Role of Enteral Monosaccharides in Intestinal Lipoprotein Production in Healthy Humans Arteriosclerosis Thrombosis and Vascular Biology ·Changting Xiao, Satya Dash, Cecilia Morgantini, Gary F. Lewis	2013	45
13	Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism Diabetes ·Changting Xiao, Satya Dash, Cecilia Morgantini, Khosrow Adeli, Gary F. Lewis	2015	44
14	Obesity and Cardiovascular Disease: The Emerging Role of Inflammation Frontiers in Cardiovascular Medicine ·Rana Khafagy, Satya Dash	2021	38
15	Oral Glucose Mobilizes Triglyceride Stores From the Human Intestine Cellular and Molecular Gastroenterology and Hepatology ·Changting Xiao, Priska Stahel, Alicia L. Carreiro, Yu-Han Hung, Satya Dash, Ian Bookman, Kimberly K. Buhman, Gary F. Lewis	2018	36
16	Intravenous Glucose Acutely Stimulates Intestinal Lipoprotein Secretion in Healthy Humans Arteriosclerosis Thrombosis and Vascular Biology ·Changting Xiao, Satya Dash, Cecilia Morgantini, Gary F. Lewis	2016	22
17	22q11.2 microdeletion and increased risk for type 2 diabetes EClinicalMedicine ·Lily Van, Tracy Heung, Sarah Malecki, Christian Fenn, Andrea Tyrer, Marcos Sanches, Eva W.C. Chow, Erik Boot, Maria Corral, Satya Dash, Susan R. George, Anne S. Bassett	2020	21
18	Residual cardiovascular risk among people with diabetes Diabetes Obesity and Metabolism ·Satya Dash, Lawrence A. Leiter	2019	19
19	Glucagon‐like peptide‐2 mobilizes lipids from the intestine by a systemic nitric oxide‐independent mechanism Diabetes Obesity and Metabolism ·Changting Xiao, Priska Stahel, Cecilia Morgantini, Avital Nahmias, Satya Dash, Gary F. Lewis	2019	18
20	Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adults Diabetes Obesity and Metabolism ·Priska Stahel, So Jeong Lee, Shawn K. Sud, Alejandro A. Floh, Satya Dash	2019	16

About Satya Dash

Satya Dash is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems, Family Practice, Physiology and Surgery, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (14 papers), Pancreatic function and diabetes (13 papers), Diet and metabolism studies (11 papers), Diet, Metabolism, and Disease (9 papers), Regulation of Appetite and Obesity (9 papers), Genetic Associations and Epidemiology (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers) and Metabolism, Diabetes, and Cancer (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (764 citations), Endocrine and Autonomic Systems (160 citations), Physiology (507 citations), Geriatrics and Gerontology (58 citations) and Biochemistry (107 citations). Satya Dash has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Changting Xiao, Gary F. Lewis, Cecilia Morgantini, Sanjeev Sockalingam, Shohinee Sarma, Linda Szeto, Robert A. Hegele, Robert Bandsma, Bruce W. Patterson and Khajag Koulajian. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes, Arteriosclerosis Thrombosis and Vascular Biology, Canadian Journal of Cardiology and Frontiers in Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact